Anti–SARS-CoV-2 Pharmacotherapies Among Nonhospitalized US Veterans, January 2022 to January 2023

IMPORTANCE: Several pharmacotherapies have been authorized to treat nonhospitalized persons with symptomatic COVID-19. Longitudinal information on the use of these therapies is needed. OBJECTIVE: To analyze trends and factors associated with prescription of outpatient COVID-19 pharmacotherapies with...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Lei, Streja, Elani, Li, Yuli, Rajeevan, Nallakkandi, Rowneki, Mazhgan, Berry, Kristin, Hynes, Denise M., Cunningham, Francesca, Huang, Grant D., Aslan, Mihaela, Ioannou, George N., Bajema, Kristina L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472184/
https://www.ncbi.nlm.nih.gov/pubmed/37651140
http://dx.doi.org/10.1001/jamanetworkopen.2023.31249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472184/
https://www.ncbi.nlm.nih.gov/pubmed/37651140
http://dx.doi.org/10.1001/jamanetworkopen.2023.31249

Ejemplares similares